| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5b78a85b839db1457e86df3dc1642a8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate |
2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c350e2ceea83b990654e74632c528831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fdb495301a330e75fd7c2c7d0d73e48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2cdf07b048f2629dc9c5602e44f99f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9e5bda5632cf89a2b16fbe8afcd5a29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2363dd970337119bebdbd7c7e206f010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff72e6403a44af267f02621aa2fd22f |
| publicationDate |
2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2726637-C1 |
| titleOfInvention |
Pharmaceutical composition and method for production thereof |
| abstract |
FIELD: medicine.SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals. First object represents a method for preparing a pharmaceutical composition, according to which the Dorogov's antiseptic stimulator fraction 2 is mixed with agar-agar or pre-dried and milled laminaria or fucus till a homogeneous mass is obtained, after which it is dried and milled. Second object is a solid pharmaceutical composition prepared according to the declared method.EFFECT: technical result consists in stability during storage for three years and non-hygroscopicity of solid pharmaceutical composition, which is obtained in accordance with disclosed method and is suitable for production of solid dosage forms containing biologically active components ASD-2F.4 cl, 10 ex |
| priorityDate |
2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |